carteolol carteolol carteolol is a non-selective beta blocker used to treat glaucoma. carteololclinical datatrade namesocupressahfs/drugs.comprofessional drug factsmedlineplusa601078license data us dailymed: carteolol routes ofadministrationeye dropsatc codec07aa15 (who) s01ed05 (who)legal statuslegal status us: ℞-only in general: ℞ (prescription only) pharmacokinetic databioavailability85%metabolismliver, active with 8-hydrocarteololelimination half-life6–8 hoursexcretionkidney (50-70%)identifiers iupac name (rs)-5--3,4-dihydroquinolin-2(1h)-one cas number51781-06-7pubchem cid2583iuphar/bps7142drugbankdb00521 ychemspider2485 yunii8nf31401xgkeggd07624 ychebichebi:3437 ychemblchembl839 ycomptox dashboard (epa)dtxsid3022746 chemical and physical dataformulac16h24n2o3molar mass292.379 g·mol−13d model (jsmol)interactive imagechiralityracemic mixture smiles o=c2nc1cccc(occ(o)cnc(c)(c)c)c1cc2 inchi inchi=1s/c16h24n2o3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19h,7-10h2,1-3h3,(h,18,20) ykey:lwafswpyphexkx-uhfffaoysa-n y (verify) it has been found to act as a serotonin 5-ht1a and 5-ht1b receptor antagonist in addition to being a beta blocker. it was patented in 1972 and approved for medical use in 1980. brand names arteolol arteoptic calte cartéabak carteol cartéol cartrol elebloc endak glauteolol mikelan ocupress poenglaucol teoptic singlauc